Radio: FDA panel approves emergency use of Pfizer’s vaccine for nationwide use
https://digital-stage.newsnationnow.com/wp-content/uploads/sites/108/2020/12/Pfizer-approval.mp3The U.S. Food and Drug Administration’s panel of outside advisors voted the Pfizer COVID-19 vaccine benefits outweigh its risk for use in individuals 16 years of age and older, effectively endorsing Pfizer’s coronavirus vaccine for emergency use authorization approval in the United States. As heard on NewsNation on Thursday, Dec. 11, 2020. Read more here.